628329-62-4

Usage

Methyl ester derivative

1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(phenylmethoxy)-, methyl ester is derived from 1-methyl-3-(phenylmethoxy)-1H-pyrazole-5-carboxylic acid by the addition of a methyl ester group.

Usage as an intermediate

1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(phenylmethoxy)-, methyl ester is commonly used in the synthesis of pharmaceuticals and agrochemicals, acting as a key building block in the creation of various drugs and chemicals.

Potential biological activities

1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(phenylmethoxy)-, methyl ester has been studied for its potential biological activities, which may contribute to its use in treating various diseases.

Versatile compound

The structure and properties of 1H-Pyrazole-5-carboxylic acid, 1-methyl-3-(phenylmethoxy)-, methyl ester make it a valuable and adaptable component in drug discovery and development processes.

Upstream product

• 100-39-0 benzyl bromide 
• 52867-42-2 5-hydroxy-2-methyl-2H-pyrazole-3-carboxylic acid methyl ester 

Downstream Products

• 1313389-24-0 3-(benzyloxy)-1-methyl-1H-pyrazole-5-carboxylic acid 
• 1354696-56-2 8-(3-{[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]methoxy}-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione 
• 1354696-62-0 8-[3-(benzyloxy)-1-methyl-1H-pyrazol-5-yl]-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione 
• 1354696-63-1 8-[(3-benzyloxy)-1-methyl-1H-pyrazol-5-yl]-1,3-dipropyl-7-(2-(trimethylsilanyl)ethoxymethyl)-3,7-dihydro-purine-2,6-dione 
• 1354696-65-3 8-(3-{[5-(3-methoxyphenyl)-1,2,4-oxadiazol-3-yl]methoxy}-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-7-{[2-(trimethylsilanyl)ethoxy]methyl}-3,7-dihydro-1H-purine-2,6-dione 
• 1354696-66-4 6-{(E)-2-[3-(benzyloxy)-1-methyl-1H-pyrazol-5-yl]vinyl}-5-nitro-1,3-dipropylpyrimidine-2,4(1H,3H)-dione 
• 1354696-67-5 6-[3-(benzyloxy)-1-methyl-1H-pyrazol-5-yl]-1,3-dipropyl-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione 

Relevant academic research and scientific papers

Novel 1,3-dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl) xanthines as potent and selective A2B adenosine receptor antagonists

Molecular modeling studies, including the comparative molecular field analysis (CoMFA) method, on 52 antagonists of the A2B adenosine receptor with known biological activity were performed to identify the three-dimensional features responsible

1,2-AZOLE DERIVATIVES WITH HYPOGLYCEMIC AND HYPOLIPIDEMIC ACTIVITY

A compound represented by the formula (1) wherein ring A is a ring optionally having 1 to 3 substituents; ring B is a 1,2-azole ring which may further have 1 to 3 substituents; Xa, Xb and Xc are the same or different and each is a bond, - O -, - S - and the like; Ya is a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; Yb and Yc are the same or different and each is a bond or a divalent aliphatic hydrocarbon residue having 1 to 20 carbon atoms; ring C is a monocyclic aromatic ring which may further have 1 to 3 substituents; and R represents -OR4 (R4 is hydrogen atom or optionally substituted hydrocarbon group) and the like, or a salt thereof or a prodrug thereof is useful as an agent for the prophylaxis or treatment of diabetes and the like.